SCYNEXIS INC SCYX

Rank #2284 · Nasdaq · $0.3B market cap

Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.

Score

26.1

P/E

-14.1

P/B

4.10

ROE

-29.2%

Op. Margin

-990.8%

Debt Ratio

49%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Weak

P/E -14.1x, P/B 4.10x. Ranks in the top 71% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -29.2%. Ranks in the top 90% of the universe.

Safety ★★★★☆

Good

Debt ratio 49%. Ranks in the top 23% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆

Poor

Revenue decline of 97.3% year over year. Ranks in the top 100% of the universe.

Safety is the relative strength · Valuation is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2014	$0.0B	$-0.0B	$-0.0B	$-0.1B	-42.7	-51
2015	$0.0B	$-0.0B	$-0.0B	$-0.1B	-1166.2	-6
2016	$0.0B	$-0.0B	$-0.0B	$-0.1B	-1166.2	-7
2017	$0.0B	$-0.0B	$-0.0B	$0.0B	-10823.7	60
2018	$0.0B	$-0.0B	$-0.0B	$0.0B	-10241.2	70
2019	$0.0B	$-0.0B	$-0.0B	$0.0B	-11666.5	102
2020	$0.0B	$-0.0B	$-0.1B	$0.0B	-40430.6	142
2021	$0.0B	$-0.1B	$-0.1B	$0.0B	–	619
2022	$0.0B	$-0.1B	$-0.0B	$0.0B	-462.2	345
2023	$0.0B	$-0.1B	$-0.1B	$0.0B	-1684.5	205
2024	$0.1B	$0.1B	$0.1B	$0.0B	51.9	1715
2025	$0.0B	$-0.0B	$-0.0B	$0.1B	-990.8	49